EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Autopsy-Confirmed Non-Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Degeneration: A Case Report

Hajime Iwata iD, Jun Ikezawa iD, Masayuki Honda, Ryo Morishima iD, Yuta Amagasaki, Tomonari Seki iD, Takahiro Kiriu, Keisuke Ishizawa, Kazushi Takahashi, Haruka Okada iD

Diagnostics · 07.07.2026 · 16 (13) · 2124

DOI: 10.3390/diagnostics16132124 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Diagnostics, online erschienen am 07.07.2026. Verfasst von Hajime Iwata und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Tokyo Metropolitan Tama Medical Center, Fuchu 183-8524, Japan. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Clinical Significance: Lambert–Eaton myasthenic syndrome (LEMS) is mediated by antibodies against P/Q-type voltage-gated calcium channels (VGCCs) and is classified as paraneoplastic (T-LEMS) or non-paraneoplastic (NT-LEMS). Cerebellar degeneration is recognized in T-LEMS, but pathological confirmation in NT-LEMS has not been reported. Case Presentation: A 79-year-old man developed progressive ataxic gait and dysarthria at age 76 and was diagnosed with LEMS based on repetitive nerve stimulation findings and anti-P/Q-type VGCC antibodies. No malignancy was identified during more than 40 months of surveillance, and comprehensive autopsy revealed no occult tumor. After hospitalization for erythroderma and pneumonia, he died of respiratory failure. Postmortem examination revealed severe Purkinje cell loss with Bergmann gliosis in the anterior lobe and tuber vermis, accompanied by torpedoes and empty baskets, without significant inflammation. These findings indicate that NT-LEMS can reach the same VGCC-associated Purkinje cell endpoint previously documented only in paraneoplastic LEMS, despite different upstream triggers. Conclusions: This first autopsy-confirmed case of NT-LEMS with cerebellar degeneration supports a shared, non-inflammatory VGCC-mediated pathway of Purkinje cell injury across LEMS subtypes.

Schlagwörter

Stichwörter der Autor:innen

Lambert–Eaton myasthenic syndromePurkinje cell lossantibody-mediatedautopsycerebellar ataxiacerebellar degenerationnon-paraneoplasticvoltage-gated calcium channel

Autor:innen und Institutionen

  • Department of Pathology, Tokyo Metropolitan Tama Medical Center, Fuchu 183-8524, Japan.
  • Department of Neurology, Tokyo Metropolitan Neurological Hospital, Fuchu 183-0042, Japan.
  • Department of Emergency and General Medicine, Tokyo Metropolitan Tama Medical Center, Fuchu 183-8524, Japan.
  • Department of Neurology, Tokyo Teishin Hospital, Chiyoda-ku, Tokyo 102-8798, Japan.
  • Department of Laboratory Medicine (Neuropathology), Tokyo Metropolitan Neurological Hospital, Fuchu 183-0042, Japan.
  • Department of Pathology, Saitama Medical University, Saitama 350-0495, Japan.

ORCID-Profile: Hajime Iwata, Jun Ikezawa, Ryo Morishima, Tomonari Seki, Haruka Okada

Zitieren

APA

Iwata, H., Ikezawa, J., Honda, M., Morishima, R., Amagasaki, Y., Seki, T., Kiriu, T., Ishizawa, K., Takahashi, K., & Okada, H. (2026). Autopsy-Confirmed Non-Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Degeneration: A Case Report. Diagnostics, 16(13), 2124. https://doi.org/10.3390/diagnostics16132124

Vancouver

Iwata H, Ikezawa J, Honda M, Morishima R, Amagasaki Y, Seki T, et al. Autopsy-Confirmed Non-Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Degeneration: A Case Report. Diagnostics. 2026;16(13):2124. doi:10.3390/diagnostics16132124

BibTeX
@article{Iwata2026,
  author = {Iwata, Hajime and Ikezawa, Jun and Honda, Masayuki and Morishima, Ryo and Amagasaki, Yuta and Seki, Tomonari and Kiriu, Takahiro and Ishizawa, Keisuke and Takahashi, Kazushi and Okada, Haruka},
  title = {Autopsy-Confirmed Non-Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Degeneration: A Case Report},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {13},
  pages = {2124},
  doi = {10.3390/diagnostics16132124}
}
Kostenlos starten →